JPRN-UMIN000032639Completed未知

Iron Supplementation on Treatment-Resistant Depressed Patients with Iron-Deficiency: A Randomized, Double-Blind, Placebo-Controlled Study - Iron for Depression Study (ID Study)

Asahi General Hospital, Department of Neuropsychiatry0 sites60 target enrollmentStarted: May 18, 2018Last updated: October 17, 2023

Conditions

Trial Snapshot

As the continuation of the research became difficult, the exam was discontinued. There was no participant.

•1) Iron-containing preparations (iron supplements, liver contrast agents for MRI, etc) within 4 weeks before providing informed consent 2) Electro-Convulsive Therapy within 4 weeks before providing informed consent 3) Unstable anti-depressant treatment for 4 weeks before providing informed consent 4) Suicide thought or attempt within six months before providing informed consent 5) With hallucinations, delusions 6) Serum hemoglobin < 10 g/dl 7) Hypersensitivity to iron-containing preparations 8) Hereditary hemochromatosis, paroxysmal nocturnal hemoglobinuria 9) Rheumatoid arthritis, thalassemia, hemolytic anemia, aplastic anemia 10) Serious infectious diseases, inflammatory diseases, cardiovascular diseases, liver diseases, renal diseases, cerebral organic diseases, blood diseases, endocrine diseases, spastic diseases, malignant tumors 11) Diagnosed as drug abuse, drug dependence, alcohol abuse, alcohol dependence 12) Pregnant women or under breast-feeding 13) HIV, HBV, HCV infection 14) The main psychotic state at the start of the test is excited or stupor 15) The doctor in charge judges he/she is ineligible

Sponsor

Asahi General Hospital, Department of Neuropsychiatry